Browsing eNauka

Browsing by Project Roche HoldingGenentech

Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)TypeМp-cat.
2020Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLCHerbst, Roy S; ...; Andric, Zoran G  ; ...; (broj, koautora 22)Article
21a+M21a+
2020Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE).Rodriguez-Abreu, Delvys; ...; Secen, Nevena M; ...; (broj, koautora 20)Conference Paper
Mp. category will be shown later
2021Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLCJassem, Jacek; ...; Andric, Zoran G  ; ...; (broj, koautora 19)Article
21a+M21a+